BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tanniou J, van der Tweel I, Teerenstra S, Roes KC. Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes. BMC Med Res Methodol 2016;16:20. [PMID: 26891992 DOI: 10.1186/s12874-016-0122-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Tanniou J, Teerenstra S, Hassan S, Elferink A, van der Tweel I, Gispen-de Wied C, Roes KC. European regulatory use and impact of subgroup evaluation in marketing authorisation applications. Drug Discovery Today 2017;22:1760-4. [DOI: 10.1016/j.drudis.2017.09.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Grobe JE, Goggin K, Harris KJ, Richter KP, Resnicow K, Catley D. Race moderates the effects of Motivational Interviewing on smoking cessation induction. Patient Educ Couns 2020;103:350-8. [PMID: 31466882 DOI: 10.1016/j.pec.2019.08.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Lawson DO, Puljak L, Pieper D, Schandelmaier S, Collins GS, Brignardello-Petersen R, Moher D, Tugwell P, Welch VA, Samaan Z, Thombs BD, Nørskov AK, Jakobsen JC, Allison DB, Mayo-Wilson E, Young T, Chan AW, Briel M, Guyatt GH, Thabane L, Mbuagbaw L. Reporting of methodological studies in health research: a protocol for the development of the MethodologIcal STudy reportIng Checklist (MISTIC). BMJ Open 2020;10:e040478. [PMID: 33334836 DOI: 10.1136/bmjopen-2020-040478] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Athauda D, Maclagan K, Budnik N, Zampedri L, Hibbert S, Aviles-Olmos I, Chowdhury K, Skene SS, Limousin P, Foltynie T. Post hoc analysis of the Exenatide-PD trial-Factors that predict response. Eur J Neurosci 2019;49:410-21. [PMID: 30070753 DOI: 10.1111/ejn.14096] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
5 Kent DM, Steyerberg E, van Klaveren D. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ 2018;363:k4245. [PMID: 30530757 DOI: 10.1136/bmj.k4245] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 23.8] [Reference Citation Analysis]
6 Mesbah S, Ball T, Angeli C, Rejc E, Dietz N, Ugiliweneza B, Harkema S, Boakye M. Predictors of volitional motor recovery with epidural stimulation in individuals with chronic spinal cord injury. Brain 2021;144:420-33. [PMID: 33367527 DOI: 10.1093/brain/awaa423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 McCreedy EM, Gutman R, Baier R, Rudolph JL, Thomas KS, Dvorchak F, Uth R, Ogarek J, Mor V. Measuring the effects of a personalized music intervention on agitated behaviors among nursing home residents with dementia: design features for cluster-randomized adaptive trial. Trials 2021;22:681. [PMID: 34620193 DOI: 10.1186/s13063-021-05620-y] [Reference Citation Analysis]
8 Brand KJ, Hapfelmeier A, Haller B. A systematic review of subgroup analyses in randomised clinical trials in cardiovascular disease. Clin Trials 2021;18:351-60. [PMID: 33478253 DOI: 10.1177/1740774520984866] [Reference Citation Analysis]
9 Sorensen PS, Kopp TI, Joensen H, Olsson A, Sellebjerg F, Magyari M. Age and sex as determinants of treatment decisions in patients with relapsing-remitting MS. Mult Scler Relat Disord 2021;50:102813. [PMID: 33578207 DOI: 10.1016/j.msard.2021.102813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Fung JYT, Lim H, Vongsirimas N, Klainin-Yobas P. Effectiveness of eHealth mindfulness-based interventions on cancer-related symptoms among cancer patients and survivors: A systematic review and meta-analysis. J Telemed Telecare 2022;:1357633X221078490. [PMID: 35212553 DOI: 10.1177/1357633X221078490] [Reference Citation Analysis]
11 Tanniou J, Smid SC, van der Tweel I, Teerenstra S, Roes KCB. Level of evidence for promising subgroup findings: The case of trends and multiple subgroups. Stat Med 2019;38:2561-72. [PMID: 30868624 DOI: 10.1002/sim.8133] [Reference Citation Analysis]
12 Bours MJL. Tutorial: A nontechnical explanation of the counterfactual definition of effect modification and interaction. J Clin Epidemiol 2021;134:113-24. [PMID: 33548464 DOI: 10.1016/j.jclinepi.2021.01.022] [Reference Citation Analysis]
13 van Agteren J, Iasiello M, Lo L, Bartholomaeus J, Kopsaftis Z, Carey M, Kyrios M. A systematic review and meta-analysis of psychological interventions to improve mental wellbeing. Nat Hum Behav 2021;5:631-52. [PMID: 33875837 DOI: 10.1038/s41562-021-01093-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Mamounas EP, Untch M, Mano MS, Huang CS, Geyer CE Jr, von Minckwitz G, Wolmark N, Pivot X, Kuemmel S, DiGiovanna MP, Kaufman B, Kunz G, Conlin AK, Alcedo JC, Kuehn T, Wapnir I, Fontana A, Hackmann J, Polikoff J, Saghatchian M, Brufsky A, Yang Y, Zimovjanova M, Boulet T, Liu H, Tesarowski D, Lam LH, Song C, Smitt M, Loibl S. Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE. Ann Oncol 2021;32:1005-14. [PMID: 33932503 DOI: 10.1016/j.annonc.2021.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mistry D, Stallard N, Underwood M. A recursive partitioning approach for subgroup identification in individual patient data meta-analysis. Stat Med 2018;37:1550-61. [PMID: 29383818 DOI: 10.1002/sim.7609] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
16 Esnault C, Gadonna ML, Queyrel M, Templier A, Zucker JD. Q-Finder: An Algorithm for Credible Subgroup Discovery in Clinical Data Analysis - An Application to the International Diabetes Management Practice Study. Front Artif Intell 2020;3:559927. [PMID: 33733209 DOI: 10.3389/frai.2020.559927] [Reference Citation Analysis]
17 Sadatsafavi M, Mansournia MA, Gustafson P. A threshold-free summary index for quantifying the capacity of covariates to yield efficient treatment rules. Stat Med 2020;39:1362-73. [PMID: 31998998 DOI: 10.1002/sim.8481] [Reference Citation Analysis]
18 Antoniou M, Kolamunnage-Dona R, Jorgensen AL. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J Pers Med 2017;7:E1. [PMID: 28125057 DOI: 10.3390/jpm7010001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
19 Ploeg J, Markle-Reid M, Valaitis R, Fisher K, Ganann R, Blais J, Chambers T, Connors R, Gruneir A, Légaré F, MacIntyre J, Montelpare W, Paquette JS, Poitras ME, Riveroll A, Yous ML; ACHRU-CPP Research Team. The Aging, Community and Health Research Unit Community Partnership Program (ACHRU-CPP) for older adults with diabetes and multiple chronic conditions: study protocol for a randomized controlled trial. BMC Geriatr 2022;22:99. [PMID: 35120457 DOI: 10.1186/s12877-021-02651-7] [Reference Citation Analysis]
20 Nagendrababu V, Duncan HF, Pulikkotil SJ, Dummer PMH. Glossary for randomized clinical trials. Int Endod J 2021;54:354-65. [PMID: 33089501 DOI: 10.1111/iej.13434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Khodayari S, Khodayari H, Ebrahimi-barough S, Khanmohammadi M, Islam MS, Vesovic M, Goodarzi A, Mahmoodzadeh H, Nayernia K, Aghdami N, Ai J. Stem Cell Therapy in Limb Ischemia: State-of-Art, Perspective, and Possible Impacts of Endometrial-Derived Stem Cells. Front Cell Dev Biol 2022;10:834754. [DOI: 10.3389/fcell.2022.834754] [Reference Citation Analysis]
22 Beaulieu D, Taylor AA, Pierce D, Cuerdo J, Schactman M, Keymer M, Ennist DL. Improving clinical trial efficiency with machine learning models of disease progression. Neurotherapeutics in the Era of Translational Medicine. Elsevier; 2021. pp. 333-66. [DOI: 10.1016/b978-0-12-816475-4.00005-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Cho AR, Lee SY. Biomarkers and their relative contributions to identifying coronary artery stenosis based on coronary computed tomography angiography in asymptomatic adults. Clin Chim Acta 2019;499:128-33. [PMID: 31520588 DOI: 10.1016/j.cca.2019.09.007] [Reference Citation Analysis]
24 Ontaneda D, Tallantyre E, Kalincik T, Planchon SM, Evangelou N. Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis. The Lancet Neurology 2019;18:973-80. [DOI: 10.1016/s1474-4422(19)30151-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
25 Saracci R. Epidemiology in wonderland: Big Data and precision medicine. Eur J Epidemiol 2018;33:245-57. [PMID: 29623670 DOI: 10.1007/s10654-018-0385-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
26 Pouteau E, Kabir-Ahmadi M, Noah L, Mazur A, Dye L, Hellhammer J, Pickering G, Dubray C. Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial. PLoS One 2018;13:e0208454. [PMID: 30562392 DOI: 10.1371/journal.pone.0208454] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
27 Effiong A, Kumari P. Pharmacotherapies for fatigue in chronic liver disease (CLD): a systematic review and meta-analysis (protocol). Syst Rev 2018;7:28. [PMID: 29444700 DOI: 10.1186/s13643-018-0688-7] [Reference Citation Analysis]
28 Loh WY, Man M, Wang S. Subgroups from regression trees with adjustment for prognostic effects and postselection inference. Stat Med 2019;38:545-57. [PMID: 29671896 DOI: 10.1002/sim.7677] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
29 Grimes DR, Heathers J. Association between magnetic field exposure and miscarriage risk is not supported by the data. Sci Rep 2021;11:22143. [PMID: 34772979 DOI: 10.1038/s41598-021-01391-3] [Reference Citation Analysis]
30 Tanaudommongkon I, John Miyagi S, Green DJ, Burnham JM, van den Anker JN, Park K, Wu J, McCune SK, Yao L, Burckart GJ. Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012-2018. Clin Pharmacol Ther 2020;108:1018-25. [PMID: 32394430 DOI: 10.1002/cpt.1886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Nimavat BD, Zirpe KG, Gurav SK. Critical Analysis of a Randomized Controlled Trial. Indian J Crit Care Med 2020;24:S215-22. [PMID: 33354045 DOI: 10.5005/jp-journals-10071-23638] [Reference Citation Analysis]
32 Oliveras I, Losilla J, Vives J. Methodological quality is underrated in systematic reviews and meta-analyses in health psychology. Journal of Clinical Epidemiology 2017;86:59-70. [DOI: 10.1016/j.jclinepi.2017.05.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
33 Chen T, King-kallimanis BL, Merzoug L, Horodniceanu EG, Fiero MH, Gao JJ, Beaver JA, Bhatnagar V, Kluetz P. US Food and Drug Administration Analysis of Patient-Reported Diarrhea and Its Impact on Function and Quality of Life in Patients Receiving Treatment for Breast Cancer. Value in Health 2021. [DOI: 10.1016/j.jval.2021.09.007] [Reference Citation Analysis]
34 Edfors R, Sahlén A, Szummer K, Renlund H, Evans M, Carrero JJ, Spaak J, James SK, Lagerqvist B, Varenhorst C, Jernberg T. Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function. Heart 2018;104:1575-82. [PMID: 29574413 DOI: 10.1136/heartjnl-2017-312436] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
35 Tanniou J, van der Tweel I, Teerenstra S, Roes KC. Estimates of subgroup treatment effects in overall nonsignificant trials: To what extent should we believe in them? Pharmaceutical Statistics 2017;16:280-95. [DOI: 10.1002/pst.1810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
36 Petkovic J, Jull J, Yoganathan M, Dewidar O, Baird S, Grimshaw JM, Johansson KA, Kristjansson E, McGowan J, Moher D, Petticrew M, Robberstad B, Shea B, Tugwell P, Volmink J, Wells GA, Whitehead M, Cuervo LG, White H, Taljaard M, Welch V. Reporting of health equity considerations in cluster and individually randomized trials. Trials 2020;21:308. [PMID: 32245522 DOI: 10.1186/s13063-020-4223-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Love RE, Adams J, van Sluijs EMF. Equity effects of children's physical activity interventions: a systematic scoping review. Int J Behav Nutr Phys Act 2017;14:134. [PMID: 28969638 DOI: 10.1186/s12966-017-0586-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
38 Götte H, Kirchner M, Sailer MO, Kieser M. Simulation-based adjustment after exploratory biomarker subgroup selection in phase II. Stat Med 2017;36:2378-90. [PMID: 28436046 DOI: 10.1002/sim.7294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
39 Lawson DO, Leenus A, Mbuagbaw L. Mapping the nomenclature, methodology, and reporting of studies that review methods: a pilot methodological review. Pilot Feasibility Stud 2020;6:13. [PMID: 32699641 DOI: 10.1186/s40814-019-0544-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]